TENS Supply Billing Fraud: Medicare Bundles and TRICARE Itemized Claims

Billing fraud in TENS supplies sold to TRICARE begins when a supplier turns a sales assumption into an order for electrodes a patient does not need or use. The Empi allegations put that decision inside the sales call. The later Electrostim Medical Services allegations brought in a different part of the same supply business: Medicare’s monthly bundle and TRICARE’s itemized claims. If you work with those orders, the quantity on the claim may tell only part of the story.

The electrodes used with that therapy became the subject of a federal healthcare fraud settlement because, the government alleged, the supplier persuaded patients to accept unjustifiably large quantities. The government challenged the need for the supplies patients accepted, reaching back to the sales conversation that produced the order.

How Empi Turned an Assumed Need Into an Electrode Order

Empi, DJO Global’s medical device subsidiary, allegedly induced TRICARE beneficiaries to order excessive electrodes by approaching them as though they had already said they needed more. In January 2018, DJO Global agreed to pay $7.62 million to resolve False Claims Act allegations covering sales from 2010 through 2015. TRICARE was the program the government said was billed for the excess electrodes.

The Department of Justice called it assumptive selling: the representative treated the need as already settled.

The department described a particularly steep increase in beneficiaries receiving unnecessary quantities during 2014 and 2015.

For someone who handled those calls or orders, the distinction is concrete. What did the patient actually say, and what need did the representative enter into the sale? The allegation puts the sales conversation at the beginning of the claim, where a billing employee reviewing the completed order might never see it.

Why Ongoing Need and Quantity Matter

A device order identifies a prescribed treatment. A recurring electrode order raises a further question: how much supply does this patient need now? Empi’s alleged practice connected those questions by assuming the answer during a sales call.

A review that stops at the signature misses what happened when the supplier chose the refill quantity. Medicare requires the supplier to keep the written order and supporting clinical documentation. The order identifies what was prescribed, while the clinical documentation helps explain the need behind it.

Medicare’s refill documentation requirements also require the request to occur and be documented before shipment. A later statement from the supplier or beneficiary cannot substitute for that record. Since January 2024, Medicare has required a documented yes to the refill without requiring the patient to count the consumable supplies left at home. The call and shipment dates remain useful evidence of how the refill began.

The TRICARE question in the Empi allegations was whether sales representatives generated orders for excessive electrodes that beneficiaries did not need or use. We connect the patient’s words, the order and the quantity billed under the program that paid the claim.

TENS Supply Claims, TRICARE Itemized Billing and Medicare’s Monthly Bundle

In the EMSI allegations, Medicare’s monthly bundle and TRICARE’s itemized claims gave the same supplies two different ways onto a bill. Medicare grouped the supplies under a monthly code. TRICARE used itemized billing. The government’s case concerned alleged exploitation of that difference to bill for excessive and medically unnecessary supplies associated with TENS and related devices.

That makes the payer part of the evidence. A monthly bundle groups supplies into a payment unit. Itemized billing puts the supplies into separate claim entries. To understand the alleged excess, the quantities shipped and the need for them belong beside the claim, whichever presentation the payer used.

A supplier employee who sees the same product move through both billing processes may know why the claim looks different after the payer is selected. We examine the clinical order, supply quantity and billing decision together. The question is what happened between the prescribed treatment and the amount of supply charged to each program.

EMSI’s Settlement Reflected Its Ability to Pay

Electrostim Medical Services, a Florida durable medical equipment supplier known as EMSI, and its founder and chairman agreed to pay $20 million in September 2024. The government alleged excessive and medically unnecessary TENS-related supplies billed to Medicare and TRICARE. The settlement amount expressly reflected the defendants’ limited ability to pay.

Empi and EMSI put recurring TENS supplies in view through different allegations. Empi’s sales contacts allegedly induced excessive orders from TRICARE beneficiaries. The EMSI allegations brought the difference between payer billing methods into the same inquiry about excessive supplies. Together, they give a supplier or payer employee a more specific starting point than a general suspicion about equipment sales.

Unbundling Durable Medical Equipment Claims: The Kinex Parallel

A separate whistleblower complaint against Kinex Medical Company alleges another way an unnecessary product can enter a claim: cold-therapy orders automatically included a brace or sling that patients did not need, followed by separate billing for the components. The whistleblower alleged:

The complaint concerns cold therapy and braces. Its useful parallel for a TENS insider is the relationship between the order and the bill. A product grouped into an order can appear separately when the supplier seeks payment.

What an Insider Can Connect

A call-center employee may recognize the assumption that generated the order. A billing employee may recognize how that order became a claim. We work with supplier employees, billing staff and people handling patient calls to connect what the patient requested, what the supplier shipped and what the payer was charged.

The recurring refill brings those decisions together again: the next contact, the next quantity and the next claim. Someone who worked on one part of that process may know why the paperwork tells a different story from the patient’s account. That is where your knowledge of the business matters, and where we work through the case with you.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know How the Refill Became a Claim

If you know who chose the electrode quantities or why the billing changed with the payer, speak with our whistleblower experts about those TENS supply claims. We work beside you to build your strongest TENS supply whistleblower case around the sales decisions, patient need and claims, and bring in durable medical equipment fraud whistleblower lawyers who know TRICARE supply billing.